Cross Marketing Group Inc. Logo

Cross Marketing Group Inc.

Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.

3675 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区西新宿三丁目20番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Established in 2003, Cross Marketing Group Inc. is a comprehensive marketing solutions provider specializing in market research, digital marketing, and data marketing. The company offers a one-stop service for both qualitative and quantitative research, with a core focus on online methodologies. Leveraging one of Japan's largest consumer research panels, it delivers actionable insights to support client decision-making for product development and strategy. The Group's services also encompass a wide range of digital marketing and data-driven solutions, assisting clients in their digital transformation (DX) and marketing process optimization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 08:33
Regulatory News Service
確認書
Japanese 8.9 KB
2025-09-24 08:32
Annual Report
有価証券報告書-第13期(2024/07/01-2025/06/30)
Japanese 1.5 MB
2025-06-24 09:01
Share Issue/Capital Change
臨時報告書
Japanese 33.6 KB
2025-03-04 02:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-02-14 08:03
Regulatory News Service
確認書
Japanese 9.0 KB
2025-02-14 08:02
Interim Report
半期報告書-第13期(2024/07/01-2025/06/30)
Japanese 242.4 KB
2025-02-04 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-01-07 03:04
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.2 KB
2024-12-03 03:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.3 KB
2024-11-05 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.5 KB
2024-10-03 08:00
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2024-10-02 05:08
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-09-27 08:06
Governance Information
内部統制報告書-第12期(2023/07/01-2024/06/30)
Japanese 23.5 KB
2024-09-27 08:06
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:05
Annual Report
有価証券報告書-第12期(2023/07/01-2024/06/30)
Japanese 1.5 MB

Automate Your Workflow. Get a real-time feed of all Cross Marketing Group Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cross Marketing Group Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Ureru Net Advertising Group Co.,Ltd. Logo
Direct marketing support for D2C e-commerce, boosting sales with patented tech & cloud services.
Japan 9235
Urteste S.A. Logo
Develops non-invasive urine tests to detect cancers early by measuring enzyme activity.
Poland URT
VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan 3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan 6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan 7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea 094850
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden VIVE
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea 310210
WDB coco CO.,LTD. Logo
CRO for pharma & med devices specializing in safety info, PMS & full lifecycle support.
Japan 7079

Talk to a Data Expert

Have a question? We'll get back to you promptly.